- Home
- CNTA vs CRGY Comparison
CNTA vs CRGY Comparison
Compare CNTA & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | CRGY |
|---|---|---|
| Founded | 2020 | 1986 |
| Country | United Kingdom | United States |
| Employees | 114 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 2.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | CRGY |
|---|---|---|
| Price | $25.66 | $8.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $37.70 | $14.10 |
| AVG Volume (30 Days) | 1.4M | ★ 5.3M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 5.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $15,000,000.00 | ★ $3,590,024,000.00 |
| Revenue This Year | N/A | $28.94 |
| Revenue Next Year | N/A | $24.77 |
| P/E Ratio | ★ N/A | $80.21 |
| Revenue Growth | ★ 118.88 | 32.31 |
| 52 Week Low | $9.60 | $6.83 |
| 52 Week High | $30.58 | $16.94 |
Technical Indicators
Market Signals| Indicator | CNTA | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 38.40 |
| Support Level | $24.17 | $8.04 |
| Resistance Level | $25.70 | $8.47 |
| Average True Range (ATR) | 1.21 | 0.34 |
| MACD | -0.43 | -0.15 |
| Stochastic Oscillator | 23.56 | 10.27 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.